Linzhi Han

Wuhan University CN

Publications

813

Citations

H-Index

i10-Index

5.0

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

28 total

PARP inhibitor plus radiotherapy reshapes an inflamed tumor microenvironment that sensitizes small cell lung cancer to the anti-PD-1 immunotherapy

Nannan Zhang, Yanping Gao, Zhengrong Huang, Panpan Dai, Yuan Luo et al. - Cancer Letters, 2022

Cited by 52 OpenAlex

Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review) PDF

Jingyi He, Zhengrong Huang, Linzhi Han, Yan Gong, Conghua Xie - International Journal of Oncology, 2021

Cited by 302 OpenAlex

RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma PDF

Xueping Jiang, Yangyi Li, Nannan Zhang, Yanping Gao, Linzhi Han et al. - Cell & Bioscience, 2021

Cited by 86 OpenAlex

HHLA2 deficiency inhibits non‐small cell lung cancer progression and THP‐1 macrophage M2 polarization PDF

Wenjie Sun, Shuying Li, Guiliang Tang, Shaoxing Sun, Yuan Luo et al. - Cancer Medicine, 2021

Cited by 53 OpenAlex

Retrospective study of gene signatures and prognostic value of m6A regulatory factor in non-small cell lung cancer using TCGA database and the verification of FTO

Hongjie Shi, Jinping Zhao, Linzhi Han, Ming Xu, Richard C. Wang et al. - Aging, 2020

Cited by 49 OpenAlex

Research Topics

Cancer Immunotherapy and Biomarkers (8) Ferroptosis and cancer prognosis (8) RNA modifications and cancer (7) interferon and immune responses (6) Lung Cancer Treatments and Mutations (5)

Affiliations

Wuhan University

CN 2026 - 2019

Zhongnan Hospital of Wuhan University

CN 2026 - 2019

Hubei Cancer Hospital

CN 2026 - 2019

Xinjiang University

CN 2023 - 2023

External Profiles

OpenAlex Profile Search Semantic Scholar Google Scholar

Share Profile

Back to Researchers

Linzhi Han

Publication & Citation Trends

Publications

PARP inhibitor plus radiotherapy reshapes an inflamed tumor microenvironment that sensitizes small cell lung cancer to the anti-PD-1 immunotherapy

Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review) PDF

RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma PDF

HHLA2 deficiency inhibits non‐small cell lung cancer progression and THP‐1 macrophage M2 polarization PDF

Retrospective study of gene signatures and prognostic value of m6A regulatory factor in non-small cell lung cancer using TCGA database and the verification of FTO

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back